Dr. David Rabin MD, PhD, a board-certified psychiatrist and translational neuroscientist, is the Chief Innovation Officer, Co-Founder, and Co-Inventor at Apollo Neuroscience; the first scientifically-validated wearable system to improve HRV, focus, sleep, and access to meditative states by delivering gentle layered vibrations to the skin. Dr. Rabin is helping to organize the world’s largest controlled study of psychedelic medicines in collaboration with colleagues at Yale, the University of Southern California, Mt. Sinai, and MAPS (Multidisciplinary Association of Psychedelic Studies) to determine the mechanisms of the dramatic therapeutic benefits observed following psychedelic-assisted psychotherapy in treatment-resistant mental illness.
Learn More:
More From Qualia: